Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$702,872
+$470,672 QoQ
Shares Held
1,415
+172.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#935
of 1,705 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $6,186,234 across 23 Biotechnology names. VRTX ranks #1 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,415 | $702,872 | |
| 2 | ALMS |
Alumis Inc.
|
23,599 | $664,075 | |
| 3 | CELC |
Celcuity Inc.
|
4,717 | $493,492 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
709 | $442,089 | |
| 5 | VNDA |
Vanda Pharmaceuticals Inc.
|
63,878 | $390,933 | |
| 6 | RPRX |
Royalty Pharma plc
|
6,772 | $379,706 | |
| 7 | INCY |
Incyte Corp
|
2,879 | $326,363 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
866 | $289,928 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $702,872 | 1,415 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $232,200 | 520 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $214,439 | 473 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $242,816 | 620 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $285,373 | 641 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $272,468 | 562 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $384,621 | 827 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $392,318 | 837 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $234,921 | 562 | Shares | Sole | 2024-07-17 | |
| 2023-12-31 | $228,672 | 562 | Shares | Sole | 2024-01-18 | |
| No filing history on record for this holder in this stock. | ||||||